How can it get any better? And yet it does…
Please welcome Erinn Bisping to the investment team at Flare Capital Partners as Director of Marketing and Investor Relations. As we start to invest our most recent fund, we recently have added a few more “healthcare rock stars” to the team and Erinn continues that theme. In addition to an impressive academic career at University of Wisconsin – Madison (BBA, double major in Finance & Investment Banking, and Economics), she has worked closely with many innovative technology companies for well over a decade, most recently at Redesign Health, where she led product, marketing, brand, and growth strategies for nearly a dozen of their new venture healthcare companies.
Successful venture capital firms routinely get an audience with great entrepreneurs and excel in thought leadership and relevance for the sector they invest in. We aspire to have those great entrepreneurs looking for us as hard as we are looking for them. Erinn will evolve many of our existing “go-to-market” initiatives and launch new ones that build a deeper sense of connectivity and community around the firm.
Importantly, she will help to further deepen our relationships with our strategic investors, who represent every corner of the healthcare industry including providers, payors, healthcare retailers, device companies, lab companies, and pharma. Our “Strategic Engagement Model” has been very productive, driving early revenues for our portfolio companies and significant co-investment. Increasingly, we have partnered with our strategic investors to co-create important new companies (see Cohere Health, Inbound Health, etc). Our more traditional financial investors (family offices, sovereign wealth funds, endowments, and foundations, etc) are also a critical constituent as they are active co-investors in many of our portfolio companies.
Quick update on our Flare Scholars program and Flare Scholar Ventures (FSV), two of our more successful initiatives. With 316 Flare Scholars, who are young brilliant passionate emerging healthcare technology entrepreneurs and investors, we launched FSV, which is our commitment to invest a portion of each fund in pre-seed rounds of Flare Scholar sponsored projects. At this point, we now have 16 FSV companies, exceeding our initial goal – and a handful of those companies have already graduated by raising proper seed or Series A rounds (in total our FSV companies have raised over $60 million). The progress of the FSV program is inspirational as we continue to on-board the next generation of great healthcare technology entrepreneurs.
As we look to recruit the Class of 2024 Flare Scholars this fall, we could not be more impressed with the quality of all our Flare Scholars, but particularly the exceptional Class of 2023. Capital will always follow great talent and in this market, it will be great talent that wins.
And please join us for our next quarterly Expert Roundtable Series webinar on June 13, 2023 at noon EST. The topic is “Value-Based Care: Does It Work?”
On the Flying Bridge 